Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake.
View / Open Files
Authors
Adriaenssens, Alice E
Biggs, Emma K
Darwish, Tamana
Tadross, John Alphonse
Sukthankar, Tanmay
Girish, Milind
Polex-Wolf, Joseph
Lam, Brain Y
Zvetkova, Ilona
Pan, Warren
Chiarugi, Davide
Publication Date
2019-11Journal Title
Cell metabolism
ISSN
1550-4131
Volume
30
Issue
5
Pages
987-996.e6
Language
eng
Type
Article
This Version
AM
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Adriaenssens, A. E., Biggs, E. K., Darwish, T., Tadross, J. A., Sukthankar, T., Girish, M., Polex-Wolf, J., et al. (2019). Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake.. Cell metabolism, 30 (5), 987-996.e6. https://doi.org/10.1016/j.cmet.2019.07.013
Abstract
Summary Ambiguity regarding the role of glucose-dependent insulinotropic polypeptide (GIP) in obesity arises from conflicting reports asserting that both GIP receptor (GIPR) agonism and antagonism are effective strategies for inhibiting weight gain. To enable identification and manipulation of Gipr-expressing (Gipr) cells, we created Gipr-Cre knockin mice. As GIPR-agonists have recently been reported to suppress food intake, we aimed to identify central mediators of this effect. Gipr cells were identified in the arcuate, dorsomedial, and paraventricular nuclei of the hypothalamus, as confirmed by RNAscope in mouse and human. Single-cell RNA-seq identified clusters of hypothalamic Gipr cells exhibiting transcriptomic signatures for vascular, glial, and neuronal cells, the latter expressing somatostatin but little pro-opiomelanocortin or agouti-related peptide. Activation of Gq-DREADDs in hypothalamic Gipr cells suppressed food intake in vivo, which was not obviously additive with concomitant GLP1R activation. These data identify hypothalamic GIPR as a target for the regulation of energy balance.
Keywords
Hypothalamus, Neurons, Animals, Mice, Inbred C57BL, Mice, Transgenic, Humans, Mice, Obesity, Gastric Inhibitory Polypeptide, Receptors, Gastrointestinal Hormone, Eating, Aged, 80 and over, Female, Glucagon-Like Peptide 1, Gene Knock-In Techniques, Glucagon-Like Peptide-1 Receptor
Sponsorship
Wellcome Trust (100574/Z/12/Z)
MRC (MC_UU_12012/3)
MRC (MC_UU_12012/5)
WELLCOME TRUST (106262/Z/14/Z & 106263/Z/14/Z)
MRC (MC_UU_12012/1)
BBSRC (BB/S017593/1)
Identifiers
External DOI: https://doi.org/10.1016/j.cmet.2019.07.013
This record's URL: https://www.repository.cam.ac.uk/handle/1810/295133
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
Licence URL: https://creativecommons.org/licenses/by-nc-nd/4.0/